Helgi van de Velde

Helgi van de Velde

Company: Sanofi

Job title: Vice President, Head of Hematologic Malignancies Strategies and Late Development


Case Study: Developing Effective Innate Cell Engager Strategies in Haematological Malignancies 9:30 am

Dual NK cell engagement to enhance antitumoural activity Trifunctional NK cell engager in AML Trifunctional NK cell engager in multiple myelomaRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.